Alprostadil - Meda
Alternative Names: Bondil; MUSE; Prostaglandin E1 - MedaLatest Information Update: 27 Apr 2024
At a glance
- Originator VIVUS
- Developer Endo, Inc.; VIVUS
- Class Erectile dysfunction therapies; Monounsaturated fatty acids; Muscle relaxants; Peripheral vasodilators; Prostaglandins; Small molecules
- Mechanism of Action Prostaglandin E1 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Erectile dysfunction
Most Recent Events
- 23 Apr 2024 Endo International has been acquired and merged into Endo, Inc.
- 05 Aug 2016 Meda has been acquired by Mylan
- 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International